Novel antibacterial agent

Abstract

The invention relates to a novel antibacterial agent. The novel antibacterial agent comprises, by mass, 4 to 6 parts of ethanol, 2 to 4 parts of polyoxyethylene carboxyl guanidine, 1.5 to 5 parts of lavender essential oil, 0.2 to 0.6 parts of mugwort essential oil, 1 to 1.5 parts of hexaglycerol monocaprylate, 2.5 to 4 parts of a hydrophobic component and 1.5 to 3 parts of a surfactant. The novel antibacterial agent is safe and mild, does not cause an allergic reaction, has stable performances and a long storage period, realizes a low cost, is prepared by simple processes and has a wide application field.

Description

technical field [0001] The present invention relates to an antibacterial agent. In particular, the present invention relates to a novel anti-microbial, anti-bacterial, anti-fungal and anti-viral antibacterial agent. Background technique [0002] At present, the conventional treatment methods used in clinical treatment of various infectious wounds are antibacterial, anti-inflammatory, and debridement. Most of the topical drugs used in the treatment process are antibacterial and anti-inflammatory drugs. But these drugs have certain shortcomings. For example, the commonly used antibiotics such as tetracycline ointment, gentamicin gauze, nitrofurazone gauze, etc., with their extensive and large-dose application, make sensitive bacteria develop corresponding resistance to them, so the effect is not good. Antibiotics only have antibacterial effects, but cannot promote the blood circulation of local tissues and inhibit the exudation of wound exudates. Therefore, once the bacteri...

AI Technical Summary

Problems solved by technology

For example, commonly used antibiotics such as tetracycline ointment, gentamicin gauze, and nitrofurazone gauze, along with their extensive and high-dose application, make sensitive bacteria resistant to them, so the curative effect is not good. Antibiotics only have antibacterial effect, but cannot promote the blood circulation of local tissues and inhibit the exudation of wound exudate. Therefore, once the bacteria develop drug resistance, the infection of the wound will further worsen, resulting in protracted consequences.

Although bacteria are not easy to develop drug resistance during treatment, their antibacterial and anti-inflammatory effects and the effect of promoting tissue healing are weak, so the wound healing period is longer

Natural products, while safe, are generally expensive and not biocidal against a broad spectrum of organisms such as Gram-negative and Gram-positive bacteria and fungi